Farallon Capital Management 13F holdings, Q3 2025
Holdings as of September 30, 2025 · filings on SEC EDGAR · latest filing →
Farallon Capital Management disclosed 139 US equity positions worth $17.7bn in its Q3 2025 13F filing. The largest position was MSFT at 5.6% of the reported book, followed by AON and EXEL. Against the Q2 2025 filing, it opened 5 new positions, added to 24 and reduced 17 among the top 50 holdings.
What did Farallon Capital Management own in Q3 2025? Top 50 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q2 2025 |
|---|---|---|---|---|---|---|---|
| 1 | MSFT MICROSOFT CORP | Technology | 5.6% | $990.9m | 1,913,135 | 9% | added |
| 2 | AON AON PLC | Financial Services | 4.6% | $812.3m | 2,278,017 | 15% | added |
| 3 | EXEL EXELIXIS INC | Healthcare | 4.6% | $805.4m | 19,501,500 | 22% | added |
| 4 | AMZN AMAZON COM INC | Consumer Cyclical | 4.3% | $769.7m | 3,505,700 | 16% | added |
| 5 | NTRA NATERA INC | Healthcare | 3.9% | $684.7m | 4,253,452 | -12% | reduced |
| 6 | RVMD REVOLUTION MEDICINES INC | Healthcare | 3.9% | $683.0m | 14,625,692 | 2% | added |
| 7 | UNH UNITEDHEALTH GROUP INC | Healthcare | 3.7% | $651.4m | 1,886,500 | 17% | added |
| 8 | TMO THERMO FISHER SCIENTIFIC INC | Healthcare | 3.4% | $610.3m | 1,258,241 | -9% | reduced |
| 9 | HIMS HIMS & HERS HEALTH INC | Healthcare | 3.4% | $609.6m | 10,746,852 | 31% | added |
| 10 | DIS DISNEY WALT CO | Communication Services | 3.4% | $595.3m | 5,198,968 | 7% | added |
| 11 | CRM SALESFORCE INC | Technology | 3.3% | $583.6m | 2,462,310 | 17% | added |
| 12 | ADSK AUTODESK INC | Technology | 3.0% | $528.2m | 1,662,852 | -5% | reduced |
| 13 | BSX BOSTON SCIENTIFIC CORP | Healthcare | 2.6% | $463.4m | 4,746,557 | 19% | added |
| 14 | IBIT ISHARES BITCOIN TRUST ETF | 2.6% | $454.5m | 6,992,700 | -0% | held | |
| 15 | WAB WABTEC | Industrials | 2.5% | $442.1m | 2,205,098 | 69% | added |
| 16 | BBIO BRIDGEBIO PHARMA INC | Healthcare | 2.4% | $425.5m | 8,192,000 | 4% | added |
| 17 | PTGX PROTAGONIST THERAPEUTICS INC | Healthcare | 2.3% | $411.6m | 6,196,006 | 0% | held |
| 18 | TRU TRANSUNION | Financial Services | 2.2% | $396.5m | 4,732,075 | -12% | reduced |
| 19 | ARMK ARAMARK | Industrials | 2.0% | $345.5m | 8,996,202 | -30% | reduced |
| 20 | INTU INTUIT | Technology | 1.9% | $333.3m | 488,088 | -9% | reduced |
| 21 | KEL KELLANOVA | 1.8% | $323.5m | 3,943,853 | 124% | added | |
| 22 | NDAQ NASDAQ INC | Financial Services | 1.8% | $320.5m | 3,623,043 | -11% | reduced |
| 23 | ADI ANALOG DEVICES INC | Technology | 1.8% | $319.3m | 1,299,500 | 2% | added |
| 24 | SCHW SCHWAB CHARLES CORP | Financial Services | 1.8% | $310.4m | 3,251,657 | -18% | reduced |
| 25 | NYT NEW YORK TIMES CO | Communication Services | 1.6% | $286.2m | 4,985,745 | -11% | reduced |
| 26 | GOOG ALPHABET INC | Communication Services | 1.5% | $273.0m | 1,120,940 | -36% | reduced |
| 27 | CBRE CBRE GROUP INC | Real Estate | 1.4% | $254.6m | 1,616,038 | -24% | reduced |
| 28 | MCK MCKESSON CORP | Healthcare | 1.4% | $252.7m | 327,100 | 4% | added |
| 29 | BEAM BEAM THERAPEUTICS INC | Healthcare | 1.4% | $244.2m | 10,063,111 | 0% | held |
| 30 | CRINETICS PHARMACEUTICALS IN | 1.4% | $240.3m | 5,770,098 | 24% | added | |
| 31 | ETHA ISHARES ETHEREUM TR | 1.3% | $234.8m | 7,450,730 | – | new | |
| 32 | AGIO AGIOS PHARMACEUTICALS INC | Healthcare | 1.3% | $232.1m | 5,781,066 | 0% | held |
| 33 | V VISA INC | Financial Services | 1.2% | $204.8m | 599,810 | 94% | added |
| 34 | LQDA LIQUIDIA CORPORATION | Healthcare | 1.1% | $194.8m | 8,565,638 | 102% | added |
| 35 | NSC NORFOLK SOUTHN CORP | Industrials | 1.0% | $184.8m | 615,000 | – | new |
| 36 | LNTH LANTHEUS HLDGS INC | Healthcare | 1.0% | $178.3m | 3,477,227 | -48% | reduced |
| 37 | IQV IQVIA HLDGS INC | Healthcare | 1.0% | $178.3m | 938,551 | -76% | reduced |
| 38 | WWD WOODWARD INC | Industrials | 0.9% | $157.2m | 621,973 | -32% | reduced |
| 39 | MA MASTERCARD INCORPORATED | Financial Services | 0.7% | $121.6m | 213,771 | 41% | added |
| 40 | CNTA CENTESSA PHARMACEUTICALS PLC | 0.6% | $105.0m | 4,331,318 | -4% | reduced | |
| 41 | TEVA TEVA PHARMACEUTICAL INDS LTD | Healthcare | 0.6% | $100.9m | 4,997,000 | – | new |
| 42 | TNGX TANGO THERAPEUTICS INC | Healthcare | 0.5% | $90.4m | 10,757,000 | 17% | added |
| 43 | BBNX BETA BIONICS INC | Healthcare | 0.5% | $85.7m | 4,313,920 | 3% | added |
| 44 | THC TENET HEALTHCARE CORP | Healthcare | 0.5% | $84.1m | 414,000 | -22% | reduced |
| 45 | GRAL GRAIL INC | 0.5% | $79.8m | 1,349,000 | 169% | added | |
| 46 | EHC ENCOMPASS HEALTH CORP | Healthcare | 0.4% | $72.5m | 571,000 | -19% | reduced |
| 47 | OSCR OSCAR HEALTH INC | Healthcare | 0.4% | $68.9m | 3,639,000 | 147% | added |
| 48 | ABVX ABIVAX SA | 0.4% | $68.3m | 805,000 | – | new | |
| 49 | MARA MARA HOLDINGS INC | Financial Services | 0.4% | $66.8m | 3,660,000 | 338% | added |
| 50 | MLYS MINERALYS THERAPEUTICS INC | Healthcare | 0.4% | $63.4m | 1,673,053 | – | new |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.